China SXT Pharmaceuticals (SXTC) Assets (2018 - 2026)
China SXT Pharmaceuticals (SXTC) posted quarterly Assets of $34.8 million for Q1 2026, up 60.43% year-over-year from $21.7 million in Q1 2025, and up 31.88% quarter-over-quarter from $26.4 million in Q3 2025.
China SXT Pharmaceuticals (SXTC) Assets (2018 - 2026) Analysis & Trends
China SXT Pharmaceuticals' Assets history runs 9 years deep, the most recent figure standing at $34.8 million for Q1 2026.
- In Q1 2026, Assets rose 60.43% year-over-year to $34.8 million; the TTM figure through Mar 2026 stood at $34.8 million (up 60.43% YoY), while the FY2026 annual figure was $34.8 million, up 60.43% from the prior year.
- Assets for Q1 2026 stood at $34.8 million, up from $26.4 million in the prior quarter.
- The five-year high for Assets was $34.8 million in Q1 2026, with the low at $14.6 million in Q3 2023.
- The 5-year median for Assets is $26.4 million (2025), against an average of $26.3 million.
- The sharpest annual moves came in 2023 and 2024: Assets tumbled 34.23% in 2023, then jumped 112.49% in 2024.
- China SXT Pharmaceuticals' Assets stood at $22.2 million in 2022, then sank by 34.23% to $14.6 million in 2023, then surged by 112.49% to $31.0 million in 2024, then slipped by 14.98% to $26.4 million in 2025, then jumped by 31.88% to $34.8 million in 2026.
- Business Quant data shows SXTC's Assets at $34.8 million in Q1 2026, $26.4 million in Q3 2025, and $21.7 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 43.71 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 39.86 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 15.08 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 98.27 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 7.22 Bn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 35.04 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 5.36 Bn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 13.56 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 6.18 Bn |
| 10 | China SXT Pharmaceuticals | 32,029.07 | -28.14 Mn | - | 34.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.75 Mn |
| Sep 30, 2025 | 26.35 Mn |
| Mar 31, 2025 | 21.66 Mn |
| Sep 30, 2024 | 31.00 Mn |
| Mar 31, 2024 | 23.13 Mn |
| Sep 30, 2023 | 14.59 Mn |
| Mar 31, 2023 | 29.55 Mn |
| Sep 30, 2022 | 22.18 Mn |
| Mar 31, 2022 | 33.55 Mn |
| Sep 30, 2021 | 22.67 Mn |
| Mar 31, 2021 | 34.55 Mn |
| Sep 30, 2020 | 24.04 Mn |
| Mar 31, 2020 | 21.70 Mn |
| Sep 30, 2019 | 23.05 Mn |
| Mar 31, 2019 | 17.47 Mn |
| Sep 30, 2018 | 7.95 Mn |
| Mar 31, 2018 | 7.66 Mn |